Ledger.Open graph →
SEC Form D · Amendment · filed December 17, 2021

Attivare Therapeutics, Inc

Offering
$7.8M
Sold
$5.9M
Exemption
Rule 506(b)
Industry
Other
Location
NATICK, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Casey Swercheck · Delray Beach, FLExecEdward Doherty · Natick, MAExecJeffrey W. Koonce · Baton Rouge, LADirectorKathleen M. Courtis · CHICAGO, ILExec · DirectorRobert Konrad · Delray Beach, FLDirectorJessica Mcdonough · Natick, MADirectorJoaquim Trias · Natick, MAExec · DirectorRobert Konrad · Delray Beach, FLExec · DirectorLuther C. Kissam Iv · Baton Rouge, LADirectorMark W. Spender · Baton Rouge, LAExecZeshan Muhammedi · Natick, MADirectorJonathan F. Frangakis · Raleigh, NCDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗